ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,301 | 66.53796 | 1 | male | 0 | 33 | 43 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 15,308.594 | 13,682.9844 | null | 8.25 | white | 28.296875 | 46 | 0.73999 | 0.590942 | 1 | 0 | 0 | no | 0.95 | 0.5 | no dnr | 33 | 59 | 8.5 | 54 | 20 | 35.29688 | null | null | null | 2.899902 | 131 | null | null | null | null | null | null | <2 mo. follow-up | 3.023926 |
3,302 | 52.392 | 1 | male | 0 | 4 | 1,638 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 2,009.25 | 1,732.7705 | null | 5 | black | 25.796875 | 30 | 0.834961 | 0.72998 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 110 | 6.299805 | 70 | 18 | 36 | 404.75 | 2.899902 | 1.099854 | 4.699219 | 140 | 7.479492 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
3,303 | 70.14899 | 1 | male | 0 | 77 | 88 | MOSF w/Malig | ARF/MOSF | 1 | 8 | null | 9 | 85,999.312 | 64,279.6875 | null | 22.5 | white | 19.097656 | 20 | 0.601929 | 0.494995 | 20 | 0 | 0 | metastatic | 0.5 | 0.3 | dnr after sadm | 1 | 94 | 6.299805 | 112 | 16 | 37.09375 | 226.90625 | 2.5 | 1.5 | 0.899902 | 139 | 7.40918 | null | null | null | null | 4 | SIP>=30 | 4 |
3,304 | 61.64297 | 1 | male | 0 | 28 | 78 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 9 | 69,951.25 | 47,864.1562 | null | 26 | white | 24 | 19 | 0.756958 | 0.679932 | 5 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 11 | 111 | 1.199951 | 82 | 11 | 37.69531 | 226.65625 | null | 1.299805 | 0.799927 | 131 | 7.429688 | null | null | null | null | null | null | 2.285645 |
3,305 | 65.396 | 1 | male | 1 | 15 | 15 | Coma | Coma | 1 | null | null | 100 | 26,288.375 | 18,995.1875 | null | 19.333328 | black | 27.898438 | 46 | 0.112991 | 0.069992 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 4 | 80 | 30.296875 | 130 | 32 | 37.89844 | 240 | 2.799805 | null | 2.199707 | 133 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 2.63916 |
3,306 | 64.17499 | 1 | female | 0 | 3 | 71 | Lung Cancer | Cancer | 1 | 8 | under $11k | 0 | 2,555.35 | 1,988.8213 | null | 5 | black | 16.699219 | 16 | 0.715942 | 0.436951 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | no dnr | 3 | 79 | 10.199219 | 100 | 20 | 36.79688 | null | null | 0.199982 | 0.799927 | 137 | null | null | null | null | 1 | 3 | adl>=4 (>=5 if sur) | 3 |
3,307 | 77.77399 | 0 | male | 0 | 25 | 1,988 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | null | null | null | 20 | white | 15.298828 | 12 | 0.825928 | 0.767944 | 19 | 0 | 0 | no | null | null | no dnr | 25 | 106 | 11.298828 | 68 | 11 | 38.59375 | 350 | null | 1.399902 | 1 | 138 | 7.5 | null | null | null | null | null | null | 1.827393 |
3,308 | 64.70398 | 1 | female | 1 | 35 | 35 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 9 | 146,233.75 | 97,332.125 | null | 44.25 | white | 25.597656 | 12 | 0.690918 | 0.598999 | 11 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 34 | 87 | 15.898438 | 94 | 14 | 37.5 | 165 | null | null | 0.599976 | 129 | 7.459961 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
3,309 | 51.362 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 44 | 18,635 | 13,307.5312 | null | 55 | black | 17.398438 | 15 | 0.834961 | 0.778931 | 1 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 5 | 117 | 8.599609 | 110 | 11 | 38.69531 | 400 | null | null | 0.699951 | 140 | 7.509766 | null | null | null | null | null | <2 mo. follow-up | 2.084473 |
3,310 | 78.66699 | 1 | female | 0 | 12 | 334 | Lung Cancer | Cancer | 4 | 8 | under $11k | 0 | 10,843.562 | 7,996.9375 | null | 9 | white | 19.5 | 28 | 0.615967 | 0.301941 | 1 | 0 | 0 | metastatic | 0.7 | 0.5 | no dnr | 12 | 93 | 4.699219 | 112 | 20 | 37 | 233.3125 | null | null | 0.599976 | 141 | 7.429688 | null | null | null | 3 | 7 | adl>=4 (>=5 if sur) | 7 |
3,311 | 65.53595 | 1 | male | 0 | 7 | 88 | Lung Cancer | Cancer | 1 | null | null | 0 | 5,538.25 | 4,378.1055 | null | 3 | white | 21.199219 | 11 | 0.613892 | 0.29895 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | no dnr | 7 | 93 | 9.798828 | 86 | 20 | 38.69531 | 342.8125 | 2.799805 | 0.299988 | 0.799927 | 138 | 7.489258 | null | null | null | null | null | null | 2.887695 |
3,312 | 62.37399 | 1 | female | 0 | 17 | 211 | Colon Cancer | Cancer | 1 | null | null | 0 | 23,129.641 | 15,278.625 | null | 9 | white | 17.597656 | 11 | 0.813965 | 0.599976 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 17 | 70 | 8 | 68 | 20 | 37.19531 | null | 3.199707 | 1 | 0.799927 | 140 | null | null | null | null | null | null | null | 2.299316 |
3,313 | 54.168 | 1 | male | 0 | 5 | 174 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 8 | under $11k | 9 | 9,294.195 | 6,839.5078 | null | 22 | white | 26.5 | 39 | 0.784912 | 0.714966 | 1 | 1 | 0 | no | null | null | no dnr | 5 | 87 | 15.599609 | 90 | 26 | 35 | 336.625 | null | null | 9.099609 | 135 | 7.419922 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,314 | 74.84198 | 1 | female | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | under $11k | 0 | 72,912.25 | 47,838.625 | null | 42.333313 | white | 28.296875 | 52 | 0.692993 | 0.600952 | 1 | 0 | 0 | no | 0.7 | 0.5 | dnr after sadm | 11 | 85 | 14.199219 | 60 | 26 | 36.59375 | 157.5 | 1.699951 | 0.899902 | 2.899902 | 138 | 7.439453 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,315 | 52.047 | 1 | male | 1 | 6 | 6 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 4,845.676 | 3,496.2949 | null | 11 | white | 23.097656 | 22 | 0.866943 | 0.778931 | 1 | 0 | 0 | no | 0.25 | 0 | no dnr | 6 | 88 | null | 100 | 32 | 35.29688 | 197.5 | 3.699707 | 1.699951 | 1 | 133 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 2.243164 |
3,316 | 57.34198 | 1 | male | 0 | 6 | 1,116 | Colon Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 5,654.199 | 3,763.8496 | null | 15 | white | 12.599609 | 22 | 0.87793 | 0.724976 | 1 | 1 | 0 | metastatic | 0.9 | 0.8 | no dnr | 6 | 129 | 2.899902 | 95 | 20 | 36.5 | null | 3.699707 | 0.399963 | 1.099854 | 139 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
3,317 | 67.92096 | 1 | male | 0 | 20 | 113 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | $11-$25k | 0 | 23,931.641 | 17,996.2188 | null | 11 | white | 14 | 19 | 0.879883 | 0.799927 | 9 | 1 | 0 | no | 0.75 | 0.5 | no dnr | 20 | 83 | null | 72 | 22 | 37 | null | null | null | 1.299805 | 139 | null | null | null | null | 2 | 7 | no(M2 and SIP pres) | 7 |
3,318 | 60.17499 | 0 | female | 0 | 10 | 1,985 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $11-$25k | 0 | 26,265.516 | 18,830.0469 | null | 23.5 | white | 16.597656 | 18 | 0.86792 | 0.821899 | 10 | 0 | 0 | no | null | null | no dnr | 10 | 100 | 7.299805 | 82 | 24 | 37.09375 | 190 | null | null | 1.099854 | 133 | 7.479492 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,319 | 75.06097 | 1 | male | 0 | 15 | 651 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | null | 0 | 36,334.688 | 23,794.0312 | null | 24 | black | 17.898438 | 28 | 0.843994 | 0.744995 | 2 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 15 | 84 | 8.699219 | 100 | 32 | 36.5 | 264 | null | null | 1.199951 | 140 | 7.469727 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,320 | 66.04797 | 1 | male | 0 | 37 | 63 | Lung Cancer | Cancer | 1 | 6 | under $11k | 0 | 31,104.797 | 24,269.2812 | null | 6.25 | black | 19.898438 | 33 | 0.643921 | 0.336975 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | no dnr | 37 | 107 | 7 | 100 | 0 | 37 | 276.1875 | null | null | 0.899902 | 138 | 7.569336 | null | null | null | 1 | 2 | null | 2 |
3,321 | 29.37399 | 0 | male | 0 | 38 | 1,984 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 13 | $11-$25k | 0 | 83,731.188 | 58,268.3125 | null | 31.75 | white | 31.699219 | 64 | 0.817993 | 0.756958 | 1 | 0 | 0 | no | 0.4 | 0.4 | no dnr | 38 | 127 | 26.699219 | 115 | 30 | 37.5 | 122 | 1.799805 | 0.5 | 7.399414 | 139 | 7.449219 | null | null | null | null | 0 | null | 0 |
3,322 | 76.31195 | 1 | male | 1 | 51 | 51 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | >$50k | 37 | 167,402.25 | 115,299.625 | null | 40.25 | white | 22.796875 | 51 | 0.661987 | 0.564941 | 1 | 1 | 0 | no | 0.7 | 0.6 | dnr after sadm | 48 | 65 | 23 | 80 | 8 | 35.69531 | 192.5 | null | 0.199982 | 11 | 135 | 7.339844 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,323 | 64.92798 | 1 | female | 0 | 27 | 46 | COPD | COPD/CHF/Cirrhosis | 2 | 13 | null | 0 | 28,759.891 | 20,046.1562 | null | 11.75 | white | 22.097656 | 26 | 0.841919 | 0.741943 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 5 | 85 | 7.699219 | 192 | 20 | 36.69531 | 247.8125 | null | null | 0.5 | 137 | 7.329102 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,324 | 40.24597 | 0 | male | 0 | 14 | 1,982 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 9 | 46,602.594 | 32,411.6406 | null | 17.666656 | white | 19.5 | 13 | 0.876953 | 0.833984 | 6 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 14 | 117 | 11.699219 | 92 | 26 | 37.79688 | 352 | null | 0.899902 | 0.599976 | 135 | 7.459961 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,325 | 37.21597 | 1 | female | 0 | 6 | 10 | CHF | COPD/CHF/Cirrhosis | 1 | 10 | null | 0 | 3,067.549 | 2,543.8203 | null | 6 | black | 21.5 | 26 | 0.912964 | 0.853882 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 6 | 79 | 9.398438 | 68 | 28 | 36.29688 | 552.375 | 3.199707 | 1.099854 | 1.799805 | 137 | 7.419922 | null | null | null | 2 | null | <2 mo. follow-up | 1.839 |
3,326 | 36.91199 | 0 | male | 0 | 4 | 1,980 | CHF | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 7,022.199 | 4,800.3203 | null | 12 | black | 18.097656 | 4 | 0.93396 | 0.886963 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 4 | 84 | 5.299805 | 54 | 22 | 35.79688 | null | null | null | 1 | 138 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,327 | 64.87598 | 1 | female | 0 | 10 | 993 | MOSF w/Malig | ARF/MOSF | 1 | 16 | $11-$25k | 0 | 38,151.344 | 24,751.4375 | null | 22 | white | 26.398438 | 26 | 0.491943 | 0.373962 | 7 | 0 | 0 | metastatic | null | null | no dnr | 10 | 131 | 16 | 68 | 26 | 35 | 155 | null | null | 1.199951 | 136 | 7.229492 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,328 | 61.68698 | 1 | female | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 68,088.938 | 45,102.3438 | null | 35 | black | 37.398438 | 79 | 0.450989 | 0.33197 | 11 | 1 | 0 | no | 0.7 | 0.7 | dnr after sadm | 2 | 67 | 11.298828 | 110 | 40 | 36.69531 | 160 | 2.899902 | 19.097656 | 1.5 | 148 | 7.509766 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,329 | 60.91397 | 1 | male | 1 | 4 | 4 | Coma | Coma | 1 | null | null | 100 | 20,829.844 | 13,774.2266 | null | 28 | white | 21.5 | 30 | 0.120987 | 0.075989 | 3 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 2 | 73 | 21.699219 | 98 | 18 | 38.89844 | 383 | null | 0.699951 | 2.199707 | 136 | 7.269531 | null | null | null | null | null | <2 mo. follow-up | 2.95459 |
3,330 | 72.09296 | 1 | male | 0 | 3 | 53 | Lung Cancer | Cancer | 1 | null | null | 0 | 2,642.119 | 2,043.2197 | null | 3 | white | 22.5 | 11 | 0.559937 | 0.237976 | 1 | 0 | 0 | metastatic | null | null | no dnr | 3 | 93 | 11.298828 | 96 | 20 | 37.09375 | null | 2.899902 | 0.299988 | 1 | 136 | null | null | null | null | null | null | <2 mo. follow-up | 2.222656 |
3,331 | 51.28 | 1 | male | 0 | 7 | 8 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 5,919.547 | 4,320.3984 | null | 9.5 | white | 31.296875 | 49 | 0.635986 | 0.453979 | 1 | 0 | 0 | no | 0.4 | 0.1 | dnr after sadm | 2 | 67 | 6.799805 | 118 | 36 | 36.59375 | 309.5 | 2.5 | null | 5.599609 | 127 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 3.286621 |
3,332 | 49.87799 | 0 | female | 0 | 6 | 1,977 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | under $11k | 0 | 9,162.547 | 6,519.2109 | null | 13 | black | 17.898438 | 23 | 0.907959 | 0.873901 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 6 | 90 | 6.699219 | 68 | 10 | 36.19531 | 271.375 | null | 1.099854 | 1 | 142 | 7.269531 | null | null | null | 7 | 7 | adl>=4 (>=5 if sur) | 7 |
3,333 | 76.71198 | 1 | male | 0 | 46 | 1,895 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | >$50k | 0 | 41,699.688 | 33,209.4062 | null | 13.75 | white | 24.699219 | 34 | 0.75293 | 0.674927 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 46 | 109 | 5 | 115 | 29 | 35.59375 | 228 | 2.699707 | 0.799927 | 1 | 142 | 7.479492 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
3,334 | 63.392 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 18 | $25-$50k | 9 | 39,656.938 | 27,532.3125 | null | 37 | white | 32.09375 | 50 | 0.634888 | 0.532959 | 1 | 0 | 0 | no | 0.4 | 0.3 | dnr after sadm | 9 | 67 | 14.199219 | 130 | 20 | 37.09375 | 180 | 2.299805 | 0.299988 | 5.299805 | 130 | 7.369141 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,335 | 68.99396 | 1 | female | 1 | 5 | 5 | Coma | Coma | 4 | null | null | 100 | 17,598.688 | 11,907.1094 | null | 30 | white | 31.5 | 47 | 0.038994 | 0.018997 | 1 | 1 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 2 | 53 | 12.798828 | 114 | 10 | 39.29688 | 323.3125 | null | 0.099991 | 4.099609 | 151 | 7.55957 | null | null | null | null | null | <2 mo. follow-up | 3.381836 |
3,336 | 61.84497 | 1 | female | 0 | 13 | 50 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 11,096.047 | 8,529.4297 | null | 18 | white | 20.898438 | 8 | 0.861938 | 0.770996 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 13 | 83 | 9.5 | 88 | 20 | 36 | null | null | 0.5 | 1 | 126 | null | null | null | null | 3 | 6 | <2 mo. follow-up | 6 |
3,337 | 76.90094 | 1 | female | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | null | 41 | null | null | null | 38 | white | 26.898438 | 43 | 0.541992 | 0.427979 | 1 | 0 | 0 | no | 0.4 | 0.25 | dnr after sadm | 5 | 130 | 11.099609 | 85 | 26 | 37.89844 | 130 | 1.699951 | 2.199707 | 0.799927 | 129 | 7.419922 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,338 | 51.63898 | 0 | male | 0 | 25 | 1,975 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 77,591.312 | 52,269.4375 | null | 24.75 | white | 26.898438 | 34 | 0.812988 | 0.695923 | 8 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 25 | 132 | 10.898438 | 138 | 11 | 37.79688 | 202.5 | null | null | 2.199707 | 151 | 7.40918 | null | null | null | null | 0 | null | 0 |
3,339 | 53.85898 | 0 | male | 0 | 9 | 1,973 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | $11-$25k | 0 | 7,230.598 | 5,601.1641 | null | 8.5 | white | 16.796875 | 11 | 0.91394 | 0.85498 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 9 | 90 | 12.099609 | 76 | 20 | 36 | null | null | 0.799927 | 1.299805 | 138 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,340 | 48.08798 | 0 | female | 0 | 19 | 1,973 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 97,578.812 | 64,881.625 | null | 32.333313 | white | 21.796875 | 14 | 0.774902 | 0.701904 | 13 | 0 | 0 | no | null | null | no dnr | 19 | 83 | 11.199219 | 110 | 26 | 39.09375 | 328.5625 | null | null | 0.799927 | 145 | 7.389648 | null | null | null | null | null | null | 2.790039 |
3,341 | 63.07498 | 1 | male | 0 | 9 | 148 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 15,978.344 | 12,662.4219 | null | 17 | white | 20.398438 | 27 | 0.863892 | 0.773926 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 9 | 73 | 8 | 112 | 20 | 36.79688 | null | null | null | 1.599854 | 135 | null | null | null | null | null | null | null | 2.358887 |
3,342 | 31.16499 | 1 | female | 1 | 26 | 26 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | $25-$50k | 37 | 94,713.188 | 61,565.8125 | null | 36.5 | white | 22.597656 | 24 | 0.759888 | 0.68396 | 7 | 0 | 0 | yes | 0.15 | 0.15 | dnr after sadm | 9 | 95 | 4.899414 | 84 | 14 | 36.69531 | 164 | null | null | 1.599854 | 141 | 7.529297 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,343 | 46.22598 | 0 | male | 0 | 223 | 1,971 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | null | 0 | 379,459.75 | 259,995.125 | null | 31 | black | 22.699219 | 18 | 0.836914 | 0.781982 | 10 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 223 | 73 | 22.796875 | 70 | 18 | 38.89844 | 134 | null | null | 0.799927 | 147 | 7.419922 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
3,344 | 50.754 | 1 | male | 0 | 38 | 63 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 15 | $25-$50k | 0 | null | null | null | 34.25 | white | 18.796875 | 28 | 0.850952 | 0.754883 | 1 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 38 | 107 | 9.699219 | 95 | 12 | 38.89844 | 200 | 1.199951 | 4.199219 | 1.099854 | 140 | 7.479492 | null | null | null | null | 0 | null | 0 |
3,345 | 68 | 1 | female | 0 | 16 | 1,382 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 28,079.641 | 17,201.5625 | null | 22 | white | 25.597656 | 28 | 0.709961 | 0.549927 | 13 | 0 | 0 | no | 0.7 | 0.4 | no dnr | 16 | 93 | 3.699707 | 105 | 24 | 37.19531 | 280 | null | 0.599976 | 4.699219 | 130 | 7.439453 | null | null | null | 2 | 5 | no(M2 and SIP pres) | 5 |
3,346 | 75.40594 | 0 | male | 0 | 39 | 1,971 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 9 | 113,901.062 | 67,952.9375 | null | 22.75 | black | 30.699219 | 56 | 0.380981 | 0.261963 | 49 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 39 | 110 | 25 | 114 | 35 | 37.29688 | 202.5 | 2 | 5.399414 | 1.599854 | 150 | 7.429688 | null | null | null | null | null | null | 3.052734 |
3,347 | 54.15997 | 1 | female | 0 | 4 | 524 | Lung Cancer | Cancer | 1 | 12 | >$50k | 0 | 3,714.449 | 2,417.3125 | null | 11 | white | 14.798828 | 9 | 0.771973 | 0.525879 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 4 | 87 | 4.599609 | 64 | 24 | 37 | null | null | 0.199982 | 0.699951 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,348 | 55.36499 | 1 | male | 0 | 4 | 831 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 3,038.5 | 2,171.8731 | null | 11 | white | 13.699219 | 12 | 0.785889 | 0.550903 | 1 | 0 | 0 | metastatic | null | 0.6 | no dnr | 4 | 73 | 7.899414 | 86 | 20 | 37.09375 | 476.1875 | null | null | 1.199951 | 141 | 7.459961 | null | null | null | 0 | 2 | no(M2 and SIP pres) | 2 |
3,349 | 43.20599 | 1 | male | 1 | 16 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 6 | null | 61 | 49,218.781 | 33,914.5938 | null | 33 | black | 37.695313 | 67 | 0.358948 | 0.240997 | 1 | 0 | 0 | no | 0.15 | 0.5 | dnr after sadm | 8 | 60 | 9.5 | 130 | 34 | 37.29688 | 120 | 2 | 16.796875 | 1.799805 | 143 | 7.419922 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
3,350 | 31.088 | 0 | male | 0 | 42 | 1,969 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 6 | $25-$50k | 37 | 68,183.562 | 50,421.75 | null | 18 | black | 20 | 5 | 0.862915 | 0.815918 | 2 | 0 | 0 | no | null | null | no dnr | 42 | 89 | 12.699219 | 84 | 15 | 35.19531 | 383.3125 | null | null | 0.799927 | 139 | 7.369141 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.641602 |
3,351 | 59.28 | 1 | female | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 44 | 17,659.438 | 12,042.7422 | null | 18 | black | 32.796875 | 50 | 0.391968 | 0.272949 | 7 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 1 | 79 | 21.5 | 130 | 22 | 37.19531 | 100 | null | 0.599976 | 1.5 | 130 | 7.389648 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
3,352 | 60.67398 | 1 | male | 1 | 15 | 15 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | null | null | null | 47 | white | 32.5 | 31 | 0.497986 | 0.379944 | 1 | 0 | 0 | yes | 0.2 | 0.3 | dnr after sadm | 15 | 96 | 5.599609 | 125 | 24 | 35.09375 | 89.40625 | null | 0.299988 | 1 | 138 | 7.509766 | null | null | null | null | null | <2 mo. follow-up | 2.536133 |
3,353 | 39.633 | 0 | female | 0 | 37 | 1,967 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 140,303.625 | 92,924.625 | null | 35.75 | white | 26.199219 | 44 | 0.816895 | 0.754883 | 8 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 37 | 105 | 27.699219 | 114 | 37 | 38.5 | 296.625 | 1.799805 | 2.599609 | 0.599976 | 132 | 7.449219 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,354 | 59.87399 | 1 | female | 0 | 60 | 298 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $11-$25k | 41 | 149,420.5 | 101,527.875 | null | 44.75 | white | 30.898438 | 41 | 0.543945 | 0.429993 | 1 | 0 | 0 | no | null | null | no dnr | 60 | 67 | 9.699219 | 118 | 36 | 39.5 | 106.65625 | 2.5 | 0.899902 | 0.599976 | 135 | 7.479492 | null | null | null | null | 0 | SIP>=30 | 0 |
3,355 | 47.97498 | 1 | male | 0 | 15 | 423 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 34,673.594 | 20,768.1875 | null | 14.333328 | black | 16.898438 | 20 | 0.92395 | 0.870972 | 1 | 0 | 0 | no | null | null | no dnr | 15 | 89 | 6.399414 | 62 | 16 | 36.39844 | null | null | 0.299988 | 1.5 | 135 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
3,356 | 60.03598 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 47,314.344 | 30,738.2656 | null | 49 | white | 23.296875 | 35 | 0.810913 | 0.748901 | 3 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 5 | 67 | 3.099609 | 75 | 26 | 38 | 353.3125 | null | 1.199951 | 2 | 136 | 7.449219 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,357 | 73.57697 | 1 | female | 1 | 34 | 34 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 6 | under $11k | 44 | 89,045.438 | 61,724.125 | null | 31.75 | black | 23.597656 | 37 | 0.608887 | 0.501953 | 2 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 12 | 111 | 15.898438 | 116 | 41 | 38.5 | 350 | 2.799805 | 1.099854 | 1.599854 | 141 | 7.459961 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
3,358 | 86.41199 | 1 | male | 1 | 4 | 4 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 61 | 18,622.797 | 12,580.5469 | null | 47 | white | 46.796875 | 61 | 0.006 | 0 | 1 | 0 | 0 | no | null | null | dnr after sadm | 2 | 43 | 12.5 | 40 | 40 | 37.09375 | 104.07812 | null | null | 3.299805 | 143 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 3.708984 |
3,359 | 32.97498 | 1 | male | 1 | 20 | 20 | Coma | Coma | 0 | 14 | $11-$25k | 100 | 74,168.5 | 50,308.7188 | null | 36.666657 | white | 20.699219 | 28 | 0.562988 | 0.494995 | 4 | 0 | 0 | no | 0.3 | 0.3 | no dnr | 20 | 120 | 25 | 95 | 37 | 38.69531 | 192.5 | null | null | 1 | 141 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,360 | 68.50696 | 1 | female | 1 | 40 | 40 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 41 | 195,778.25 | 126,928.938 | null | 41 | white | 25.699219 | 28 | 0.55188 | 0.438965 | 6 | 0 | 0 | no | null | null | dnr after sadm | 31 | 107 | 28.296875 | 100 | 36 | 36.09375 | 250 | 3.199707 | 1.299805 | 0.699951 | 131 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 2.275391 |
3,361 | 36.16199 | 0 | female | 0 | 47 | 1,963 | Coma | Coma | 0 | 12 | null | 100 | 120,483.062 | 79,610 | null | 35.75 | white | 22.597656 | 25 | 0.53894 | 0.469971 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 47 | 77 | 18.796875 | 110 | 25 | 36.19531 | 277.125 | 3.599609 | 1.299805 | 0.899902 | 137 | 7.489258 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,362 | 49.12299 | 1 | male | 0 | 23 | 141 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 32,006.594 | 22,374.8281 | null | 26.666656 | white | 25.898438 | 23 | 0.844971 | 0.744995 | 1 | 0 | 0 | no | null | null | no dnr | 23 | 63 | 6.699219 | 74 | 24 | 36.79688 | null | null | 2.5 | 1.299805 | 118 | null | null | null | null | 1 | 0 | null | 0 |
3,363 | 24.049 | 1 | male | 0 | 22 | 29 | CHF | COPD/CHF/Cirrhosis | 4 | 14 | under $11k | 0 | null | null | null | 18.666656 | black | 28.597656 | 40 | 0.870972 | 0.785889 | 3 | 0 | 0 | no | null | null | no dnr | 22 | 88 | 30 | 112 | 36 | 38 | 322.8125 | null | 9.798828 | 1.199951 | 136 | 7.449219 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
3,364 | 30.76799 | 1 | male | 0 | 17 | 71 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 20,983.391 | 15,626 | null | 11 | black | 26.898438 | 37 | 0.859985 | 0.81189 | 2 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 17 | 67 | 12.199219 | 80 | 30 | 39.29688 | 276.1875 | 2.399902 | 7.099609 | 0.599976 | 131 | 7.489258 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
3,365 | 76.40497 | 1 | female | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 9 | 130,559.938 | 87,684.9375 | null | 46.333313 | white | 19.097656 | 37 | 0.687988 | 0.594971 | 29 | 0 | 0 | yes | null | null | dnr after sadm | 12 | 58 | 13.298828 | 68 | 25 | 39.29688 | 316.625 | 2.099609 | null | 0.899902 | 135 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,366 | 46.53 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 11 | null | 0 | 21,262.891 | 15,565.0938 | null | 41 | white | 32.195313 | 63 | 0.747925 | 0.667969 | 1 | 0 | 0 | no | null | null | dnr after sadm | 6 | 61 | 15 | 122 | 8 | 37.29688 | 196 | 3 | 3.899902 | 2.399902 | 135 | 7.269531 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,367 | 44.60498 | 0 | male | 0 | 31 | 1,957 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 26 | 148,688 | 103,548.562 | null | 21.25 | black | 29.699219 | 51 | 0.616943 | 0.511963 | 31 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 31 | 133 | 9.599609 | 90 | 22 | 37.5 | 440 | 2.599609 | 23.699219 | 2.799805 | 136 | 7.329102 | null | null | null | null | 7 | no(M2 and SIP pres) | 7 |
3,368 | 71.69098 | 1 | male | 1 | 4 | 4 | Coma | Coma | 2 | null | null | 100 | 12,116.844 | 8,462.4375 | null | 36 | white | 30.898438 | 73 | 0.035995 | 0.016998 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 2 | 55 | 10.5 | 152 | 50 | 38 | 282.8125 | null | 0.5 | 7.5 | 138 | 7.219727 | null | null | null | null | null | <2 mo. follow-up | 2.905273 |
3,369 | 64.94995 | 1 | female | 0 | 36 | 48 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 37 | 62,986.688 | 43,444.7188 | null | 26.5 | black | 28.898438 | 59 | 0.265991 | 0.159973 | 3 | 0 | 0 | metastatic | null | null | no dnr | 36 | 52 | 24.699219 | 180 | 7 | 38 | 260 | 2.5 | 2.399902 | 1.699951 | 141 | 7.529297 | null | null | null | null | null | <2 mo. follow-up | 3.849609 |
3,370 | 46.85797 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 6 | under $11k | 55 | 73,627.125 | 50,169.4062 | null | 40.5 | white | 36.59375 | 78 | 0.313965 | 0.199982 | 6 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 9 | 68 | 28.699219 | 100 | 29 | 38.09375 | 186 | 2.899902 | 24.5 | 6.299805 | 144 | 7.399414 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,371 | 67.70197 | 1 | male | 0 | 8 | 39 | Lung Cancer | Cancer | 1 | null | null | 0 | 7,427.547 | 5,059.1406 | null | 13.5 | white | 20.097656 | 28 | 0.634888 | 0.324951 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 2 | 83 | 12.599609 | 100 | 36 | 36.19531 | 308 | null | 0.299988 | 1.099854 | 143 | 7.459961 | null | null | null | null | null | <2 mo. follow-up | 2.849121 |
3,372 | 38.883 | 1 | male | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 9 | 25,195.344 | 16,901.6562 | null | 30 | black | 30.398438 | 34 | 0.780884 | 0.709961 | 1 | 0 | 0 | no | 0.85 | 0.75 | dnr after sadm | 10 | 70 | 11 | 98 | 9 | 34.59375 | 384 | null | 3.599609 | 0.399963 | 142 | 7.489258 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
3,373 | 76.06799 | 1 | male | 0 | 5 | 70 | Lung Cancer | Cancer | 1 | null | null | 0 | 3,971.6 | 3,286.3984 | null | 5 | white | 14.298828 | 23 | 0.734985 | 0.465942 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 74 | 7.599609 | 88 | 24 | 36.59375 | 480.9375 | null | null | 1.099854 | 142 | 7.5 | null | null | null | null | null | null | 2.061035 |
3,374 | 65.52197 | 1 | male | 0 | 7 | 80 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 16 | $25-$50k | 0 | 5,249.898 | 3,816.7031 | null | 9.5 | black | 16.199219 | 20 | 0.719971 | 0.563965 | 1 | 0 | 0 | metastatic | null | null | no dnr | 7 | 87 | 3.099609 | 84 | 20 | 36.5 | null | 2.399902 | 2.599609 | 0.799927 | 137 | null | null | null | null | 0 | 1 | adl>=4 (>=5 if sur) | 1 |
3,375 | 62.366 | 1 | female | 0 | 4 | 14 | Colon Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 2,857.299 | 2,059.7793 | null | 10 | white | 41.398438 | 50 | 0.241974 | 0.029999 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | no dnr | 4 | 78 | 13 | 110 | 36 | 36 | null | 2.299805 | 4 | 1 | 131 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,376 | 57.64798 | 1 | female | 0 | 21 | 322 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $25-$50k | 0 | 45,167.531 | 31,629.2344 | null | 27 | white | 21.097656 | 38 | 0.807983 | 0.743896 | 3 | 1 | 0 | yes | null | null | no dnr | 21 | 78 | 11 | 112 | 40 | 38.5 | 290 | null | null | 1.099854 | 138 | 7.519531 | null | null | null | 3 | 0 | null | 0 |
3,377 | 56.60498 | 0 | female | 0 | 3 | 1,952 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 4,187.199 | 2,915.0039 | null | 4 | white | 15.398438 | 14 | 0.918945 | 0.861938 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 67 | 6.899414 | 68 | 20 | 36 | null | null | 0.599976 | 1.199951 | 139 | null | null | null | null | null | null | null | 1.932617 |
3,378 | 63.04199 | 1 | male | 0 | 236 | 1,441 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $25-$50k | 0 | 504,659.5 | 338,955 | null | 46 | white | 19.898438 | 34 | 0.844971 | 0.791992 | 3 | 0 | 0 | no | 0.75 | 0.7 | dnr after sadm | 148 | 72 | 18.199219 | 120 | 10 | 37.79688 | 267.5 | 1.799805 | 0.399963 | 1.399902 | 137 | 7.389648 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,379 | 21.13599 | 1 | male | 0 | 32 | 275 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 163,675.25 | 110,659.25 | null | 29.25 | white | 27.296875 | 41 | 0.843994 | 0.790894 | 20 | 0 | 0 | no | null | null | no dnr | 32 | 143 | 16.296875 | 68 | 8 | 35.09375 | 260 | 2.5 | 9.798828 | 0.899902 | 147 | 7.509766 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,380 | 58.32199 | 1 | female | 0 | 7 | 877 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 15,772.445 | 11,455.75 | null | 19.5 | white | 25.398438 | 36 | 0.835938 | 0.731934 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 90 | 13.599609 | 110 | 20 | 37.19531 | 148 | null | null | 0.599976 | 138 | 7.459961 | null | null | null | 4 | 0 | no(M2 and SIP pres) | 0 |
3,381 | 44.97998 | 1 | female | 0 | 15 | 674 | Colon Cancer | Cancer | 1 | null | null | 0 | 14,023.094 | 10,758.6016 | null | 12.333328 | white | 12.398438 | 17 | 0.894897 | 0.758911 | 1 | 0 | 0 | metastatic | 0.9 | 0.75 | no dnr | 15 | 97 | 7.199219 | 72 | 16 | 36.79688 | null | 4.099609 | 5.299805 | 0.699951 | 139 | null | null | null | null | null | null | null | 2.092773 |
3,382 | 53.43997 | 0 | male | 0 | 53 | 1,950 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $25-$50k | 55 | 88,128.812 | 63,449.3438 | null | 32.5 | white | 33.59375 | 60 | 0.438965 | 0.31897 | 1 | 0 | 0 | no | null | null | no dnr | 53 | 65 | 16.699219 | 125 | 31 | 38.19531 | 152 | 3.399902 | 2.699707 | 7.399414 | 133 | 7.369141 | null | null | null | null | 6 | no(M2 and SIP pres) | 6 |
3,383 | 65.17999 | 1 | male | 0 | 52 | 103 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 5 | under $11k | 0 | 96,142.25 | 65,433.5938 | null | 25.75 | white | 17.199219 | 22 | 0.883911 | 0.841919 | 1 | 0 | 0 | no | 0.95 | 0.94 | no dnr | 52 | 112 | 15.398438 | 85 | 15 | 37.19531 | 266.625 | 1.699951 | 0.599976 | 0.899902 | 131 | 7.469727 | null | null | null | 4 | null | null | 3.183199 |
3,384 | 70.69397 | 1 | male | 0 | 18 | 865 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 9 | 22,192.984 | 16,123.9609 | null | 18 | white | 25.199219 | 31 | 0.7229 | 0.637939 | 2 | 0 | 0 | no | null | null | no dnr | 18 | 74 | 12 | 90 | 19 | 35.5 | 316 | 2.599609 | 5.799805 | 0.899902 | 133 | 7.349609 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
3,385 | 62.806 | 1 | male | 0 | 5 | 362 | Lung Cancer | Cancer | 2 | 10 | $25-$50k | 0 | 6,054.199 | 3,734.2539 | null | 10 | white | 11.099609 | 25 | 0.810913 | 0.593994 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 5 | 135 | 15.099609 | 92 | 20 | 36.79688 | null | 4.099609 | 0.5 | 1.5 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,386 | 45.38498 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 49,908.031 | 33,091.8125 | null | 50 | black | 26.898438 | 16 | 0.665894 | 0.56897 | 12 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 8 | 80 | 5.899414 | 115 | 26 | 36.09375 | 282.8125 | null | null | 0.699951 | 130 | 7.339844 | null | null | null | null | null | <2 mo. follow-up | 2.750488 |
3,387 | 44.13998 | 0 | male | 0 | 84 | 1,947 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | 148,803.75 | 101,513.938 | null | 26.25 | black | 24.296875 | 26 | 0.853882 | 0.802979 | 2 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 84 | 123 | 11.298828 | 115 | 38 | 37.59375 | 175.5 | 2.799805 | 0.899902 | 1 | 142 | 7.399414 | null | null | null | null | 0 | null | 0 |
3,388 | 76.33099 | 1 | female | 1 | 24 | 24 | Coma | Coma | 0 | null | null | 100 | null | null | null | 21.333328 | black | 14.798828 | 19 | 0.355957 | 0.282959 | 1 | 0 | 0 | no | 0.01 | 0.000001 | dnr after sadm | 5 | 125 | 15 | 85 | 22 | 37.29688 | 243.3125 | null | null | 1.099854 | 141 | 7.439453 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
3,389 | 77.11694 | 1 | male | 1 | 21 | 21 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 37 | null | null | null | 38 | white | 30.398438 | 50 | 0.279968 | 0.17099 | 8 | 0 | 0 | yes | 0.4 | 0.1 | no dnr | 21 | 55 | 17.898438 | 110 | 14 | 36 | 140 | 1.599854 | 0.399963 | 1.099854 | 151 | 7.389648 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,390 | 53.11697 | 1 | male | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 6 | under $11k | 9 | 36,496.094 | 25,353.0469 | null | 28.666656 | black | 41.296875 | 51 | 0.453979 | 0.333984 | 1 | 0 | 0 | no | null | null | dnr after sadm | 13 | 72 | 24.296875 | 98 | 24 | 35.39844 | 344.4375 | 2.5 | 50.195313 | 2.099609 | 134 | 7.40918 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
3,391 | 50.64999 | 0 | male | 0 | 38 | 1,945 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $25-$50k | 0 | null | null | null | 13.75 | white | 12 | 7 | 0.935913 | 0.911987 | 2 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 38 | 82 | 8.398438 | 70 | 16 | 37.29688 | 466.625 | null | 0.399963 | 1.099854 | 141 | 7.379883 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
3,392 | 72.47894 | 1 | male | 1 | 4 | 4 | Lung Cancer | Cancer | 1 | null | null | 100 | null | null | null | 21 | white | 49.398438 | 58 | 0 | 0 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 43 | 12.298828 | 0 | 0 | 36.59375 | 108.32812 | null | 0.799927 | 0.899902 | 133 | 7.179688 | null | null | null | null | null | <2 mo. follow-up | 3.746094 |
3,393 | 66.90997 | 1 | female | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | $11-$25k | 9 | null | null | null | 44 | other | 21.898438 | 37 | 0.770996 | 0.697998 | 5 | 1 | 0 | no | 0.8 | 0.512 | dnr after sadm | 17 | 72 | 11.5 | 120 | 40 | 38.09375 | 271.375 | null | null | 1.099854 | 138 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,394 | 58.42798 | 1 | female | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 81,086.875 | 55,463.9688 | null | 44 | white | 26.5 | 35 | 0.455994 | 0.336975 | 35 | 0 | 0 | metastatic | 0.75 | 0.3 | dnr before sadm | -8 | 67 | 18 | 135 | 10 | 38 | 276.625 | 2.699707 | 1 | 2.899902 | 145 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 2.383301 |
3,395 | 53.09497 | 0 | male | 0 | 32 | 1,946 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | null | 55 | 57,829.438 | 41,323.5312 | null | 24.5 | white | 18.699219 | 20 | 0.768921 | 0.694946 | 2 | 0 | 0 | no | null | null | no dnr | 32 | 100 | 15.199219 | 70 | 28 | 37.59375 | 212 | null | 0.699951 | 0.699951 | 136 | 7.40918 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,396 | 42.95697 | 0 | male | 0 | 22 | 1,945 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 45,774.219 | 32,444.4531 | null | 36 | white | 38.695313 | 65 | 0.630981 | 0.527954 | 1 | 0 | 0 | no | 0.8 | 0.9 | no dnr | 22 | 67 | 28.5 | 125 | 24 | 38.69531 | 59 | 1.299805 | 1.599854 | 4.5 | 149 | 7.429688 | null | null | null | null | 2 | adl>=4 (>=5 if sur) | 2 |
3,397 | 61.38797 | 1 | female | 0 | 7 | 81 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 7,101.348 | 5,534.457 | null | 4 | white | 15.798828 | 9 | 0.738892 | 0.472961 | 1 | 0 | 0 | metastatic | 0.3 | 0.05 | no dnr | 7 | 94 | 7 | 86 | 18 | 36.19531 | null | null | null | 0.899902 | 135 | null | null | null | null | 1 | 6 | adl>=4 (>=5 if sur) | 6 |
3,398 | 30.63699 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 24,373.297 | 17,057.125 | null | 58 | black | 42.09375 | 70 | 0.596924 | 0.488953 | 2 | 0 | 0 | no | null | null | no dnr | 5 | 131 | 16.097656 | 220 | 36 | 35.5 | 465 | null | 32.59375 | 1.699951 | 151 | 7.509766 | null | null | null | null | null | <2 mo. follow-up | 1.937256 |
3,399 | 51.77298 | 1 | male | 0 | 23 | 236 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 71,611.188 | 49,917.3438 | null | 31.333328 | white | 41.59375 | 69 | 0.136993 | 0.063995 | 23 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 23 | 54 | 0.099991 | 90 | 36 | 39.09375 | 115 | null | 1.099854 | 2.5 | 136 | 7.389648 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,400 | 80.41595 | 0 | female | 0 | 14 | 1,940 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 13 | under $11k | 0 | 19,865.688 | 14,454.7734 | null | 20.333328 | white | 32.09375 | 55 | 0.430969 | 0.311951 | 4 | 0 | 0 | yes | 0.6 | 0.5 | no dnr | 14 | 112 | 18.296875 | 140 | 37 | 35.19531 | 142.84375 | 2.199707 | 0.399963 | 1.299805 | 136 | 7.489258 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.